本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

POINT BIOPHARMA GLOBAL INC

12.50
+0.0000
成交量:- -
成交额:4,112.71万
市值:13.32亿
市盈率:13.92
高:12.50
开:12.50
低:12.50
收:12.50
数据加载中...
2023/12/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/27

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/12/27

重要事件披露

Form 8-K - Current report
2023/12/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/14

重要事件披露

Form 8-K - Current report